Fort Lee, NJ (PRWEB) May 16, 2013
Herborium® Group, Inc. (OTC Pink: HBRM), http://www.herborium.com, a Botanical Therapeutics® Company, is pleased to announce that the company’s all-botanical acne treatment, AcnEase®, has been improved to enhance the customer experience with increased bio-availability and an improved coating which provides for easier swallowing. The global revenues in the acne market are $3 billion, and a steady growth of the market for acne therapeutics is expected to continue until 2018 with the USA and EU leading the demand with a combined 120 million acne sufferers. Adult acne is on the rise, and the average age of an acne sufferer has increased over the past 10 years from 20.5 years to to 26.5 years of age. Many of these individuals are unable to resolve their acne problem for years, and they become a chronic acne sufferer.
To help combat this chronic acne condition, and to meet and exceed customer needs and satisfaction, AcnEase®, is now enhanced with better bio-availability resulting from a more technologically advanced manufacturing process, and has an improved all natural coating which makes it easier for those who have difficulty in swallowing tablets.
The process for preparing the herbal ingredients has been modified yielding finer extract blends, which lead to improved content uniformity in the AcnEase® tablets. The ingredients have not changed; efforts were focused on achieving reliable consistent extraction and milling of the raw materials.
Some individuals experience difficulty in swallowing tablets. The new AcnEase® tablets have an improved all natural coating which facilitates swallowing. Visual inspection of the tablets will reveal a smoother, shinier surface that makes the tablets easier to swallow.
AcnEase® is unique in that the herbal ingredients present in the tablets not only help eliminate existing blemishes but, most importantly, prevents new acne pimples from forming while restoring physiologic balance that is disrupted in those individuals with persistent acne.
Dr. Agnes Olszewski, CEO of Herborium, comments, “As a result of these manufacturing improvements, an already great product is now even better. These improvements are a reflection of Herborium’s continuing commitment to our valued customers needs and satisfaction.”
About Herborium Group, Inc.
Herborium Group, Inc., a Botanical Therapeutics® company, focuses on developing, licensing, and marketing proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company uses clinical validation to establish and maintain a differential advantage. The company sells its products in the USA and Europe. For more information, please visit http://www.herborium.com, http://www.acnease.com and http://www.herboriumsh.com.
One of our most important responsibilities is to communicate with shareholders in an open and direct manner. Comments are based on current management expectations, and are considered "forward-looking statements," generally preceded by words such as "plans," "expects," "believes," "anticipates," or "intends." We cannot promise future returns. Our statements reflect our best judgment at the time, and we disclaim any obligation to update or alter forward-looking statements as the result of new information or future events. The Company urges investors to review the risks and uncertainties contained within its filings with the OTC Markets and/or Securities and Exchange Commission.
For more information, please inquire: Investorsrelations(at)herborium(dot)com.